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Abstract
During the first trimester of human pregnancy, Natural Killer (NK) cells of the maternal uterine mucosa (e.g. decidua) have a
unique phenotype and are involved in crucial physiological processes during pregnancy. We investigated whether
modifications of the NK receptor repertoire occur during the first trimester of pregnancy. We found significantly decreased
expression of KIR2DL1/S1 and KIR2DL2/L3/S2 receptors, NKp30 and NKp44 activatory receptors, and the CD85j (ILT-2)
inhibitory receptor. We also observed significantly increased expression of the NKG2D activatory receptor at the decidual NK
cell surface. By flow cytometry, we further highlighted an evolution of NK subsets between 8 and 12 weeks of gestation,
with a shift from the KIR2DL1/S1
+/KIR2DL2/L3/S2
+ subset towards the double negative subset, coupled with a decrease of
the CD85j
+/NKG2D
2 subset in favour of the CD85j
2/NKG2D
+ subset. Furthermore, cell surface expression of NK receptor
ligands, including CD85j and NKG2D ligands, has been characterized by flow cytometry on decidual immune CD14
+ and
CD3
+ cells. HLA-G, the high affinity ligand of CD85j, was detected on both cell types. In contrast, NKG2D ligands ULBP-2
ULBP-3 and MICA/B were not expressed on CD14
+ and CD3
+ cells, however a variable expression of ULBP-1 was observed.
The ligand expression of KIR2DL1/S1 and KIR2DL2/L3/S2 was also analyzed: the HLA-C molecule was expressed at a low
level on some CD14
+ cells whereas it was not detected on CD3
+ cell surface. NK receptor ligands are known to be also
expressed on the invading placental trophoblast cells. Thus, the phenotypic evolutions of decidual NK cells described in this
present study may preserve their activation/inhibition balance during the first trimester of pregnancy.
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Introduction
Natural killer (NK) cells are a component of the innate immune
system, and play an important role in the initiation of an efficient
immune response. They can eliminate pathogen-infected cells as
well as transformed tumor cells, by using a broad panel of
inhibitory and activatory receptors [1,2]. The main NK receptors
belong to the Ig-like superfamily (KIR, LILR, NCR) or the C-type
lectin family (NKG2 receptors) [3]. These receptors recognize
MHC class I molecules including HLA-A, -B, -C, -E and -G; but
also stress-inducible proteins or viral proteins [4]. NK cells are
widely present throughout the human body and are found in
peripheral blood [5], the liver [6], the gut [7] and the female
reproductive tract [8]. Moreover, these innate immune cells are
involved in the pathogenesis of several infections. For example,
NKG2D, CD85j (also known as ILT-2, LILRB-1 and LIR-1) and
NKp44, among other NK receptors, appear to be crucial for
mechanisms of control of Cytomegalovirus or Human Immuno-
deficiency Virus type 1 infections [9,10,11]. Studies reported
during the last decade have shown that the roles of NK cells are
not restricted to a killing function. Indeed evidence exists for
regulatory and building activities, especially concerning uterine
NK cells within the female reproductive tract [12].
Between 6 and 7 days after ovulation, the blastocyst-stage egg
attaches to the uterine mucosa and invades the monostratified
epithelium. This process induces the placental development. After
the initial step of nidation, the differentiation of placental
trophoblast cells follows two distinct pathways: villous and
extravillous. During the first trimester of pregnancy, extravillous
trophoblast cells (EVT) derived from the placenta progressively
invade the maternal uterine mucosa (i.e. the decidua) and then the
inner third of the myometrium.
During the first trimester of pregnancy, NK cells represent the
most abundant immune cells in the decidua [13]. These decidual
NK (dNK) cells are CD56
bright/CD16
negative and are distinct from
peripheral blood NK subsets [14]. At this time, the dNK cells are
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e30017crucial for the maintenance of pregnancy and their functions
mainly involve cell-to-cell contact and the secretion of a large
panel of cytokines, chemokines and growth factors [15,16]. dNK
cells produce pro-angiogenic factors (IFN-c, VEGF, Ang2 etc.),
which stimulate the remodelling of the uterine spiral arteries [17].
These cells also secrete IL-8 and CXCL-10 that stimulate EVT
cell invasion [18]. During this process, dNK cells are in close
contact with EVT cells; however they do not kill these semi-
allogenic cells [19]. Despite the fact that dNK cells contain large
intracellular amounts of perforin and granzyme A, they do not
release their cytolytic granules during a healthy pregnancy [20].
Moreover, dNK cell functions also involve interactions with other
immune decidual cells, such as CD14
+ antigen presenting cells and
CD3
+ T lymphocytes [21,22]. While expression of dNK ligands on
human trophoblast cells is well described [18,19,21,23], less is
known concerning their surface expression on immune decidual
cells.
During pregnancy, the structure of the decidual mucosa is
modified. The EVT cells invade the mucosa in depth [24].
Moreover, the immune composition of the decidual tissue evolves
with time. After a massive recruitment or proliferation of NK cell
subsets, the number of dNK cells decreases from the end of the
first trimester until the end of pregnancy [25]. In addition to the
change in the dNK cell proportion, the role of dNK cells is also
modified during pregnancy. Studies have shown several functional
differences between dNK cells at the end of the first trimester of
pregnancy (8 to 10 weeks of gestation) and those of the second
trimester (12 to 14 weeks of gestation) [26]. dNK cells secrete more
angiogenic factors during the first trimester [17] and larger
amounts of IL-6, IL-8 and IFN-c in the second trimester [26].
Recently, it was shown that the first trimester dNK cells are much
more capable of stimulating trophoblast invasion than the second
trimester dNK cells [27].
In the present study, we investigated whether modifications of
the NK repertoire at the surface of dNK cells occur during the first
trimester of pregnancy. We showed that the expression of CD85j,
NKG2D, NKp30, NKp44, KIR2DL1/S1 and KIR2DL2/L3/S2
receptors at the cell surface evolves between 8 and 12 weeks of
gestation. We were able to characterize a strong association
between the expression levels of several of these receptors and to
demonstrate for the first time the dynamics of the CD85j/NKG2D
dNK subsets. We also detected NK receptor ligands at the cell
surface of decidual immune CD14
+ and CD3
+ cells. CD85j ligand
(HLA-G) and ULBP-1, one of the ligand of NKG2D, were
observed on both cell types. Others NKG2D ligands were not
detected. Common ligand of KIR2DL1/S1 and KIR2DL2/L3/
S2 (HLA-C) was only observed at a low level on few CD14
+ cells.
Previous data have shown that the invading placental trophoblast
cells also express NK receptor ligands [19,23,28,29]. Thus our
results suggest that the dynamic expression of NK receptors may
ensure the activation/inhibition balance of dNK cells during the
trophoblast invasion process.
Results
Decidual NK cells express inhibitory and activatory
receptors with varying donor-specific percentage of
expression
To characterize the dNK cell repertoire, we performed flow
cytometry analysis of 20 NK receptors on freshly isolated decidual
mononuclear cells (n=28) (Fig. 1). We confirmed that dNK cells
express the KIR which bind to HLA-C (KIR2DL1/S1,
KIR2DL2/L3/S2 and KIR2DS4) but also express KIR3DL1/
S1 and the KIR which binds to HLA-G, KIR2DL4. The NCR
activatory receptors (NKp46, NKp30 and NKp44) and NKG2D
were also detected at the dNK cell surface, however a few
percentage of dNK cell express the NKG2C activatory receptor.
dNK cells also expressed inhibitory receptors such as CD94/
NKG2A and CD85j. The majority of dNK cells were positive for
the 2B4 co-receptor and the CD69 activation marker. Moreover,
we confirmed that dNK cells did not express the CD16 and
CD160 receptors at their surface. We showed for the first time that
the CD161 and NKp80 receptors were expressed at the dNK
surface at a high and low percentage, respectively. Furthermore
we also established that the DNAM-1 receptor is not expressed.
Importantly, we observed variations in NK receptor cell surface
expression between donor samples for the majority of NK
receptors; with the exception of CD16, NKp46, CD94, CD160,
DNAM-1, and 2B4 (Fig. 1). Since the samples were obtained
between 8 and 12 weeks of gestation, these variations might be
related to time of gestation.
Expression of NK receptors on the dNK cells evolves
during the first trimester of pregnancy
To assess whether the expression of NK receptors was modified
during the first trimester of pregnancy, we analyzed the surface
expression of each of the 20 studied NK receptors between 8 and
12 weeks of gestation on freshly isolated decidual mononuclear
cells (n=28) (Fig. 2). Using a linear regression test, we observed a
significant decrease in the surface expression of the CD85j
inhibitory receptor over this period (p=0.027). Moreover the
extent of surface expression of the NKp30 and NKp44 activatory
receptors also decreased significantly (p=0.013 and p=0.002
respectively), whereas expression of the NKG2D activatory
receptor at the dNK cell surface was significantly increased
(p=0.027) over the same gestational period. As previously
reported [30], the KIR2DL1/S1 and KIR2DL2/L3/S2 KIR
receptors were significantly decreased between 8 and 12 weeks of
gestation (p=0.005 and p=0.017 respectively). In contrast, the
expression of CD69, NKp46, NKG2A (Fig. 2), NKG2C, CD94,
2B4, KIR2DL4, KIR3DL1/S1, KIR2DS4, NKp80 and CD161
(data not shown) receptors remained stable.
Correlation of NK receptor expressions on decidual NK
cells
To assess whether the dNK receptors were linked to each other,
we used the Spearman’s rank coefficient to measure the statistical
correlation between NK receptors whose expression increased or
decreased between 8 and 12 weeks of gestation (Table 1). The
results show that the percentage of surface expression of NKG2D
was inversely correlated to that of CD85j (p=0.0003) and of
KIR2DL1/S1 (p=0.004). The surface expression of KIR2DL1/
S1 correlated positively to that of KIR2DL2/L3/S2 (p=0.0002)
and of CD85j (p,0.0001). Furthermore, the expression of the
CD85j inhibitory receptor was correlated to that of KIR2DL2/
L3/S2 (p=0.004). In contrast, the surface expression of NKp30
and NKp44 receptors was not significantly correlated to that of the
other receptors (Table 1).
Evolution of decidual NK subpopulations during the first
trimester of pregnancy
Because of the strong correlation between KIR2DL1/S1 and
KIR2DL2/L3/S2 expression, we analyzed the evolution of the
dNK subsets that expressed these markers during the first trimester
of pregnancy by flow cytometry (Fig. 3 A & B). The results showed
that the majority of KIR2DL1/S1
+ dNK cells co-expressed the
KIR2DL2/L3/S2 receptor at 8 weeks of gestation. During the
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+/KIR2DL2/L3/S2
+ dNK
subset decreased significantly (p=0.010), while the proportion of
cells that did not express these receptors (KIR2DL1/S1
2/
KIR2DL2/L3/S2
2 cells) increased significantly (p=0.008). The
percentage of cells of an intermediate phenotype, expressing one
or the other receptor (KIR2DL1/S1
+/KIR2DL2/L3/S2
2 or
KIR2DL1/S1
2/KIR2DL2/L3/S2
+) remained stable between 8
and 12 weeks of gestation (p=0.590 and p=0.215 respectively).
Because of their opposing functions (inhibitory versus activatory,
respectively) and their roles in HIV-1 infection [9,10], we also
studied the linked evolution between the CD85j and NKG2D
receptors during the first trimester of pregnancy (Fig. 4 A & B). We
showed that the majority of dNK cells from early samples (8
th
week of gestation) expressed the CD85j but not the NKG2D
receptor (subset CD85j
+/NKG2D
2). Between the 9
th and the 10
th
week of gestation, dNK cells began to express the NKG2D
receptor and lose CD85j expression. Finally, the loss of CD85j
expression was more pronounced for late samples (11
th week of
gestation) and the majority of dNK cells became CD85j
2/
NKG2D
+ at this time (Fig. 4 A). Analysis of the evolution of the
four NK subsets (CD85j
+/NKG2D
2, CD85j
+/NKG2D
+,
CD85j
2/NKG2D
+, CD85j
2/NKG2D
2) confirmed that the
subset that expressed only CD85j (CD85j
+/NKG2D
2) decreased
significantly as pregnancy progressed (p=0.031)(Fig. 4 B). The
subset expressing only the NKG2D receptor (CD85j
2/NKG2D
+)
increased at the end of the first trimester of pregnancy (p=0.012).
The other subsets (CD85j
+/NKG2D
+ and CD85j
2/NKG2D
2)
remained stable during the first trimester of pregnancy (p=0.198
and p=0.964 respectively).
Altogether our results indicate that the phenotype of dNK cells
evolves during the first trimester of pregnancy.
Expression of the NK receptor ligands on the decidual
CD14
+ antigen presenting cells and CD3
+ T lymphocytes
during the first trimester of pregnancy
Because we have previously shown their permissivity to HIV-1
infection [31] and because of their interactions with dNK cells, we
analyzed NK receptor ligand expression at the cell surface of the
decidual CD14
+ antigen presenting cells (dAPC) and CD3
+ T
lymphocytes (dLT). To characterize their phenotypes, we
performed flow cytometry analysis of 10 ligands on freshly isolated
decidual mononuclear cells from the first trimester of pregnancy
(n=13) (Fig. 5, Table 2, Fig. S1). CD48 protein, the ligand of 2B4,
was expressed by some dLT cells but was not or weakly detected
on dAPC surface as previously described [21]. The dAPC and
dLT cells expressed CD155 and CD112, the ligands of DNAM-1,
but at different levels (Fig. 5 and Fig. S1). In contrast, the
expression of the non-classical MHC class I, HLA-E, the ligand of
NKG2A and NKG2C, was not or weakly observed. Some dAPC
express at low level HLA-C whereas it was not detected at the dLT
surface. We previously described that the pan MHC class I
antibody W6/32 recognized all dAPC [31] and dLT cells (data not
shown). We observed HLA-G expression, one of the CD85j
ligand, on some dAPC and dLT cells. Furthermore, the NKG2D
ligands, ULBP-2, ULBP-3 and MICA/B were not expressed at the
cell surface of freshly isolated dAPC and dLT cells. However, a
large percent of both cell types presented at their cell surface the
ligand of NKG2D, ULBP-1.
Since expression of dNK receptors evolves during the first
trimester of pregnancy, we investigated whether the expression of
their respective ligands was modulated during this period. Using
linear regression test, we determined that expression of the dNK
receptor ligands on dAPC and dLT cell surfaces remained stable
on the samples studied (data not shown).
Altogether, these results indicate that ligands of dNK receptors
are expressed on dAPC and dLT cell surface at different levels.
Discussion
In the present study, we provide evidence that the phenotype of
dNK cells is dynamic during the first trimester of pregnancy. We
first confirmed and strengthened the particularity of the dNK
phenotype, by analyzing of the expression of 20 NK receptors at
the cell surface. Our results confirmed that dNK cells expressed
markers of both CD56
dim and CD56
bright peripheral blood NK
subsets. For the first time, we show that dNK cells express NKp80
and CD161 receptors, and that DNAM-1 receptor is absent from
the dNK cell surface. In contrast, most of peripheral blood NK
cells express this activatory receptor (data not shown). This marker
can thus be used in combination with others to distinguish dNK
cells from peripheral blood NK cells.
We observed an evolution of NK receptors at the surface of
dNK cells as pregnancy progressed. In fact, the surface expression
of KIR2DL1/S1 and KIR2DL2/L3/S2 receptors, NKp30 and
NKp44 activatory receptors, and the CD85j (ILT-2) inhibitory
Figure 1. Expression of the NK receptor repertoire at the surface of decidual NK cells during the first trimester of pregnancy.
Decidual mononuclear cells were analyzed by flow cytometry immediately after isolation. The analyses were gated on the CD56
+/CD3
2 population.
Box-and-whisker plots represent percentages of positive cells for each receptor. Analyses were performed on decidual cells from 28 different donors
between 8 and 12 weeks of gestation.
doi:10.1371/journal.pone.0030017.g001
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expression of NKG2D activatory receptor significantly increased
during the first trimester of pregnancy. These evolutions were
specific to dNK cells, since the expression of these same NK
receptors by decidual T CD3
+ cells (dLT) remained stable (data
not shown). The decrease of NK receptor expression could be due
to increased interactions with their respective ligands as it has been
reported that ligand binding can induce the down-regulation of
NK receptors [32,33]. Indeed, we and others have shown that the
ligands of these receptors are effectively expressed at the materno-
fetal interface [18,21,23]. HLA-C molecule, ligand of KIR2DL1/
S1 and KIR2DL2/L3/S2, has been highly detected on placental
extravillous trophoblasts [28] and weakly observed in decidual
stromal cells [34]. In the present study, we showed that HLA-C is
expressed at a low level on CD14
+ dAPC. Placental trophoblast
cells do not express HLA-A and HLA-B [35], however, they
express a combination of HLA-C, HLA-E and HLA-G [19,28,29].
We detected low expression of HLA-E, the ligand of NKG2A and
NKG2C, on dAPC surface. The CD85j receptor binds MHC class
I molecules and preferentially interacts with the HLA-G molecule
[18]. HLA-G is mainly expressed by placental trophoblast cells
and play a crucial role in immunoregulatory functions during
pregnancy [36]. The present study showed that HLA-G is detected
on some decidual immune cell surface (dAPC and dLT). The
ligands of NKG2D were absent from the surface of healthy
trophoblast [21]. We observed that ULBP-1 is the only NKG2D
ligand expressed at the surface of dAPC and dLT cells. The
ULBP-1 expression on decidual immune cells might be related to
the cell maturation status [37,38] and cytokines microenvironment
[39] as it has been previously described on peripheral antigen
presenting cells. Other studies have shown that the ligands of
NKp44 are expressed by trophoblasts [23]. The ligands of NKp30
and NKp44 are also detected within decidual tissue [18]. The
binding of anti-NKp30 does not induce a cytolytic activity of dNK
cells [40]. Conversely, the binding of anti-NKp46 receptor
antibody stimulates the cytolytic activity of dNK cells in vitro
[40], but the cognate ligands have not been detected at the
materno-fetal interface [18]. Moreover, our results show that
expression of NKp46 at the dNK cell surface is not modified
during the first trimester of pregnancy. dAPC and dLT express
CD155 and CD112 whereas their cognate receptor DNAM-1 is
not detected at dNK cell surface. Finally, we confirmed that the
ligand of 2B4, CD48 protein, is expressed by some decidual CD3
+
T lymphocytes [21].
A previous study reported a decrease of KIR2DL1/S1 and
KIR2DL2/L3/S2 expression at the dNK cell surface between 6
and 12 weeks of gestation [30]. This modulation was observed
only for dNK cells and HLA-C binding KIR, and not for
peripheral blood NK cells (pNK) and HLA-B binding KIR.
Figure 2. NK receptor repertoire evolution of dNK cells during
the first trimester of pregnancy. Expression of NK receptors on
decidual mononuclear cells was analyzed between 8 and 12 weeks of
gestation. Graphs represent the percentage of marker expression (Y)
and the day of gestation (X). The line represents the linear regression. A
p-value,0.05 was significant. The analyses were performed on decidual
cells from 28 different donors, individually represented by a dot.
doi:10.1371/journal.pone.0030017.g002
Table 1. Spearman correlation coefficient (p-value) of surface expression between NK receptors (n=28).
NKp44 CD85j NKG2D NKp30 KIR2DL1/S1 KIR2DL2/L3/S2
NKp44 1 0. 38 (0.05) 20.26 (0.18) 0.39 (0.04) 0.28 (0.15) 0.638 (0.04)
CD85j 1 20.62* (0.0003) 0.13 (0.51) 0.78 (,0.0001) 0.53 (0.004)
NKG2D 1 20.214 (0.49) 20.452 (0.004) 20.39 (0.04)
NKp30 1 0.27 (0.17) 0.25 (0.20)
KIR2DL1/S1 1 0.65 (0.0002)
KIR2DL2/L3/S2 1
*Bold data are statistically significant (p-value #0.004).
doi:10.1371/journal.pone.0030017.t001
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their study. It should be noticed that the commercially available
antibodies to detect KIR2DL1/S1 and KIR2DL2/L3/S2 do not
allow the distinction between the activatory or inhibitory function
of these receptors.
At the beginning of the first trimester of pregnancy, the dNK
cell activity is mainly regulated by the decidual cells (stromal cells,
decidual antigen presenting cells…) through soluble factors and
ligand-receptor interactions [21,34]. We showed, in the present
study, that ligands of NK receptors were also expressed by
decidual immune cells. Subsequently, the frequency of the ligand-
receptor interactions would increase due to extravillous tropho-
blast invasion. Because of the expression of HLA-C, HLA-G,
NKp44-L by trophoblasts, the probability of stimulating the
corresponding receptors increases upon trophoblast invasion. The
phenotype evolution of the dNK subsets could result from different
processes: the downregulation of dNK receptors after ligand
binding [32,33], the phenotypic shift of the dNK population or the
clonal expansion of specific dNK subsets. The expression of
receptors such as NKp44, CD85j, KIR2DL1/S1 and KIR2DL2/
L3/S2 at the dNK cell surface would decrease to ensure the cell
activation balance. The activation homeostasis of dNK cells would
be preserved, despite variations of the stimulation signals within
the decidua during pregnancy. In line to the previously reported
modulation of dNK secretion profiles [17,26], first trimester
evolution of NK receptor expression could impact on cytokine and
angiogenic factor release. Indeed, previous studies reported that
the binding of anti-NKp30, anti-NKp44 or anti-NKG2D
antibodies at the dNK cell surface induces the secretion of soluble
factors such as IFN-c, TNF-a, CCL-3, CCL-4 and angiogenic
factors [18]. Modulation of dNK receptor expressions would so
modify the secretion profile of dNK cells during the pregnancy as
Figure 3. Evolution of the KIR2DL1/S1 - KIR2DL2//L3/S2 dNK subset during the first trimester of pregnancy. Decidual mononuclear
cells were analyzed by flow cytometry immediately after isolation. dNK cells were defined as the CD3
2/CD56
+ population within the decidual cells. (A)
KIR2DL1/S1 and KIR2DL2/L3/S2 co-expression was analyzed on samples taken at 57 days (early, red), 66 days (middle, blue) and 81 days of gestation
(late, green). Representative donor analyses are shown individually and overlaid (right dot plot). (B) Linear regression for each subset percentage
within the dNK cells (Y) and day of gestation (X). The analyses were performed on decidual cells from 28 different donors, individually represented by
a dot.
doi:10.1371/journal.pone.0030017.g003
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different amounts of angiogenic factors and cytokines during the
first trimester of pregnancy, compared to the second [17,26].
Overall, these studies showed an evolution of dNK cell functions
during pregnancy. Moreover, the increase of NKG2D expression
may help to protect the fetus against pathogenic infections, since
the NKG2D ligands, MICA/B and ULBP1-5, are mainly induced
by cellular stresses such as cell damage or pathogen infection
[41,42]. The dNK cells could have an antiviral activity against
infected decidual cells during the pregnancy mediated through
cytolysis or through soluble factors such as cytokines and
chemokines. Earlier in the first trimester of pregnancy, when
NKG2D is not expressed on dNK cells, antiviral activity could be
mediated by CD85j as it has been previously described on
peripheral NK cells [9,10].
In conclusion, in this study, we have shown that the phenotype
of dNK cells is dynamic during the first trimester of pregnancy.
Evolution of NK receptor expression could preserve the activation
homeostasis of dNK cells. Our results highlight for the first time an
evolution of the dNK cell phenotype from CD85j
+ to NKG2D
+.
These two receptors are known to mediate antiviral activity of NK
cells in the periphery by distinct mechanisms [9,10]. Even if there
is no functional evidence in the literature for a sentinel role of
dNK cells against pathogens, a role of dNK cells in the control of
pathogen transmission has repeatedly been suggested [43,44].
However, in addition to their known builder function [12], dNK
cell antiviral activities still need to be demonstrated.
Methods
Ethics statement
All the women donors in this study provided their written
informed consent. The study was approved by the ethics
committee of the Ho ˆtel Dieu (Paris, France), the Assistance
Figure 4. Evolution of the CD85j - NKG2D dNK subset during the first trimester of pregnancy. Decidual mononuclear cells were analyzed
by flow cytometry immediately after isolation. The dNK cells were defined by the CD3
2/CD56
+ population within the decidual cells. (A) CD85j and
NKG2D co-expression was analyzed on samples taken at 57 days (early, red), 63 days (middle, blue) and 78 days of gestation samples (late, green).
Representative donor analyses are shown individually and overlaid (right dot plot). (B) Linear regression for each subset, percentage within the dNK
cells (Y) and day of gestation (X). The analyses were performed on decidual cells from 28 different donors, individually represented by a dot.
doi:10.1371/journal.pone.0030017.g004
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Agence de Biome ´decine (nu PFS08-013) and the biomedical
research committee of the Institut Pasteur, Paris, France (nu
RBM/2005.024).
Human decidual tissue collection
Decidual tissue samples were obtained from 43 healthy women
who underwent voluntary pregnancy termination during the first
trimester of pregnancy (8–12 weeks of gestation) at the Antoine
Be ´cle `re Hospital, Clamart, France or the Tenon Hospital, Paris,
France. Samples used for the NK repertoire were distributed as
followed: 8–9 weeks of gestation (n=11), 9–10 weeks of gestation
(n=5), 10–11 weeks of gestation (n=6) and 11–12 weeks of
gestation (n=6). Samples used for the NK ligand repertoire were
distributed as followed: 8–9 weeks of gestation (n=3), 9–10 weeks
of gestation (n=3), 10–11 weeks of gestation (n=6) and 11–12
weeks of gestation (n=3). Decidua basalis were separated from the
other tissues, collected, and then washed using RPMI 1640
Glutamax medium (Gibco, Invitrogen, Cergy Pontoise, France)
supplemented with 10% fetal calf serum (PAA, Les Mureaux,
France) to eliminate blood and placental contaminants.
Isolation of decidual mononuclear cells
The freshly isolated decidual basalis tissue was minced and
digested under agitation for 1 hour at 37uC, in RPMI 1640
(Gibco) with 1 mg/ml collagenase IV (Sigma, St Quentin
Fallavier, France) and 50 U/ml recombinant DNase I (Roche,
Meylan, France). The cell suspension was filtered successively
through 100, 70 and 40 mm sterile nylon cell strainers (BD
Biosciences). The mononuclear cell population was isolated using
Lymphocyte Separation Medium (PAA).
Antibodies
The following antibodies were used for the gating of decidual
immune cells: Amcyan labelled anti-CD45 (2D1); PacificBlue-
labeled anti-CD14 (M5E2); FITC-conjugated anti-CD69 (FN50);
PE-TexasRed-labeled anti-CD3 (UCHT1); Alexa700-labeled anti-
CD56 (B159). A donkey anti-mouse IgG-PE was used for the
Figure 5. Expression of the dNK receptor ligands at the surface of decidual CD3
+ and CD14
+ cells during the first trimester of
pregnancy. Decidual mononuclear cells were analyzed by flow cytometry immediately after isolation. The analyses were gated on the CD45
+/CD3
+
or on the CD45
+/CD14
+ populations. Box-and-whisker plots represent percentages of positive cells for each ligand. Analyses were performed on
decidual cells from at least 12 different donors (n=12–15) between 8 and 12 weeks of gestation.
doi:10.1371/journal.pone.0030017.g005
Table 2. Antibodies used for the NK receptor and NK ligand
repertoires.
NK receptor Abs Clone Ligands Clone
2B4 (CD244)-PE-Cy5 C1.7
(1)* CD48-APC 394607
(3)
CD160-PE BY55
(1) HLA-C L31
(4)
CD85j (ILT-2)-PE HP-F1
(1) HLA-G-APC MEM-G/9
(5)
HLA-C L31
(4)
DNAM-1 (CD226)-FITC DX11
(2) CD112 (Nectin-2)-PE R2 477.1
(1)
CD155 (PVR)-PE 300907
(3)
KIR2DL1/S1 (CD158a/h)-FITC HP3E4
(2) HLA-C L31
(4)
KIR2DL2/L3/S2
(CD158b/j)-APC
GL183
(1) HLA-C L31
(4)
KIR2DL4 (CD158d)-FITC 181703
(2) HLA-G-APC MEM-G/9
(5)
KIR2DS4 (CD158i)-PE FES172
(1) HLA-C L31
(4)
KIR3DL1/S1 (CD158e)-PE Z27.3.7
(1)
NKG2A (CD159a)-APC 131411
(3) HLA-E MEM-E/08
(5)
NKG2C (CD159c)-APC 134591
(3) HLA-E MEM-E/08
(5)
NKG2D (CD314)-APC ON72
(1) MICA/B-APC 159207
(3)
ULBP1-PE 1708118
(3)
ULBP2-APC 165903
(3)
ULBP3 166510
(3)
CD94-FITC HP3D9
(2)
CD161-PE-Cy5 DX12
(2)
CD16-PacificBlue 3G8
(1)
NKp30 (CD337)-Alexa 647 P30-15
(2)
NKp44 (CD336)-PE Z231
(1)
NKp46 (CD335)-PE BAB281
(1)
NKp80-APC 239127
(3)
*Manufacturer:
(1) BD,
(2) Beckman Coulter,
(3) R&D System,
(4) Kind Gift A.G.
Siccardi,
(5) Exbio.
doi:10.1371/journal.pone.0030017.t002
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isotype matched Ig were used as controls. The antibodies used for
the NK receptor and the NK ligand repertoires were presented
Table 2.
NK receptor and NK ligand repertoire analysis on
decidual cells
Decidual mononuclear cells were directly stained for surface
markers after isolation and subsequently fixed with 1% parafor-
maldehyde solution (EMS, Hatfield, USA). FACS data were
acquired using a LSRII 2-Blue 2-Violet 3-Red 5-Yelgr laser
configuration (BD Biosciences). Flow cytometry analyses were
performed by Diva (BD Biosciences) and FlowJo 9.0.1 (Tristar)
software. For the NK receptor repertoire, analyzed cells were
gated on lymphocyte populations that had been defined by FSC/
SSC, then NK cells were defined as CD56
+/CD3
2 cells. At least
10 000 events in the CD56
+/CD3
2 (NK cell) gate were analyzed
in each test. For the NK ligand repertoire, dAPC were defined as
CD45
+/CD14
+ cells and dLT cells as CD45
+/CD3
+ cells. At least
1 000 events in the dAPC and dLT cell gates were analyzed.
Statistical analysis
Linear regression tests were performed to assess the correlation
of NK receptor and NK ligand variations over the progression of
pregnancy. A p value of ,0.05 was considered to be statistically
significant.
Two by two correlations between NK receptors for which the
expression significantly increased or decreased between 8 and 12
weeks of gestation were estimated with the Spearman coefficient.
Adjustments for multiple tests were performed using the method
proposed by Benjamini and Hochberg (1995), which controls the
False Discovery Rate (FDR). Correlation coefficients were
considered to be statistically significant when the associated p
value was #0.004. Statistical analyses were performed using Prism
4 software (Graph Pad).
Supporting Information
Figure S1 Cell surface expression of dNK receptor
ligands on decidual immune cells. Decidual CD14
+ cells
(A) and decidual CD3
+ cells (B) were stained with Allophycocya-
nin-conjugated (CD48, ULBP-2, HLA-G, MICA/B), Phycoery-
thrin-conjugated (CD155, CD112, ULBP-1), or unconjugated
(HLA-C, HLA-E, ULBP-3) mAb (grey histograms). Unstained
cells or PE-conjugated goat anti-mouse IgG stained cells were used
as controls (dotted lines). The numbers indicate the x-fold increase
in mean fluorescence intensity over the control. This experiment is
representative of n=12 decidual samples.
(TIF)
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